banner

Newsletter

New MJFF Funding Programs

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) on February 20  will launch a series of new funding programs open to both academic and industry researchers. The organization estimates allocating $55 million in 2013 to the research programs.

MJFF will seek projects promoting drug development for Parkinson’s disease around exciting therapeutic pathways and targets, including but not limited to programs on alpha-synuclein and LRRK2. Access to MJFF’s growing inventory of pre-clinical and clinical tissues and resources to address promising Parkinson’s ideas will also be made available. 2013 funding programs include:

Dyskinesia Challenge 2013
Deadline: No deadline; applications accepted anytime
One-year grants to identify and validate novel dyskinesia targets

LRRK2 Challenge 2013
Deadline: No deadline; applications accepted anytime
One-year grants to uncover new insight into LRRK2 Parkinsonism

LRRK2 Pharmacodynamic Assays 2013
Deadline: Pre-proposals due April 3, 2013 at 6pm US EDT
Two-year grants to identify and validate robust biological measures of LRRK2 function useful for therapeutic development

MJFF Biosample and Tissue Resources 2013
Deadline: Pre-proposals due April 3, 2013 at 6pm US EDT
One-year grants to support use of preclinical or clinical tissue or biosamples for any of the following analyses:

  • Biochemical
  • Pathological
  • PD diagnostic marker identification
  • PD progression marker evaluation
  • Diurnal fluctuation of markers of interest

Neurotrophic Factors Challenge 2013
Deadline: No deadline; applications accepted anytime
One-year grants to accelerate development of neurotrophic factor therapies

Rapid Response Innovation Awards
DeadlineNo deadline; applications accepted anytime
One-year grants to jump start new ideas in PD research

Synuclein Therapeutic Acceleration Program 2013
DeadlineFull proposals due April 17, 2012 at 6pm US EDT
Two-year grants to advance development of mid-to late-stage alpha-synuclein therapeutic lead small molecules/biologics

Target Validation 2013
Deadline: Pre-proposals due May 29, 2013 at 6pm US EDT; additional program deadline in fall 2013
Two-year grants to nominate new therapeutic targets for Parkinson’s disease.

Therapeutic Pipeline Program 2013
Deadline: Pre-proposals due April 3, 2013 at 6pm US EDT; additional program deadline in fall 2013
Two-year (preclinical) and three-year (clinical) grants to accelerate therapeutic development (early screening, hit-to-lead optimization, pre-IND testing, clinical studies) around key Parkinson’s disease targets.

For additional information, contact Tracey Mumford, Associate Director, Research Partnerships at tmumford@michaeljfox.org. Visit MJFF’s “Apply for a Grant” page for more information and application instructions at https://www.michaeljfox.org/research/apply-for-grant.htmlTo receive email updates about MJFF research programs and news, write to research@michaeljfox.org.